Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) – Equities researchers at Leerink Swann upped their Q4 2016 earnings per share (EPS) estimates for shares of Zeltiq Aesthetics in a report released on Thursday. Leerink Swann analyst R. Newitter now expects that the firm will earn $0.15 per share for the quarter, up from their prior estimate of $0.10. Leerink Swann has a “Outperform” rating and a $48.00 price target on the stock. Leerink Swann also issued estimates for Zeltiq Aesthetics’ FY2017 earnings at $0.28 EPS and FY2018 earnings at $0.78 EPS.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its quarterly earnings data on Wednesday, November 9th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.08 by $0.04. Zeltiq Aesthetics had a negative return on equity of 6.45% and a net margin of 9.48%. The firm earned $95.20 million during the quarter, compared to analyst estimates of $90.84 million. During the same quarter in the prior year, the business posted $0.05 EPS. The business’s revenue for the quarter was up 55.6% compared to the same quarter last year.

Earnings History and Estimates for Zeltiq Aesthetics (NASDAQ:ZLTQ)

ZLTQ has been the topic of several other research reports. Maxim Group lifted their price target on shares of Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday, August 9th. Stifel Nicolaus lifted their target price on shares of Zeltiq Aesthetics from $38.00 to $52.00 and gave the company a “buy” rating in a report on Wednesday, September 21st. Zacks Investment Research upgraded shares of Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a report on Saturday, July 23rd. Brean Capital reiterated a “buy” rating on shares of Zeltiq Aesthetics in a report on Monday, October 24th. Finally, Northcoast Research reiterated a “buy” rating on shares of Zeltiq Aesthetics in a report on Tuesday. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Zeltiq Aesthetics has an average rating of “Buy” and an average target price of $42.78.

Shares of Zeltiq Aesthetics (NASDAQ:ZLTQ) opened at 39.41 on Friday. The stock’s 50 day moving average price is $37.67 and its 200 day moving average price is $33.39. The stock has a market cap of $1.57 billion, a price-to-earnings ratio of 50.85 and a beta of 0.89. Zeltiq Aesthetics has a one year low of $18.41 and a one year high of $41.48.

Several institutional investors have recently modified their holdings of the company. Louisiana State Employees Retirement System increased its position in shares of Zeltiq Aesthetics by 0.7% in the second quarter. Louisiana State Employees Retirement System now owns 14,300 shares of the company’s stock worth $391,000 after buying an additional 100 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Zeltiq Aesthetics by 2.1% in the third quarter. PNC Financial Services Group Inc. now owns 5,218 shares of the company’s stock worth $205,000 after buying an additional 107 shares during the last quarter. Municipal Employees Retirement System of Michigan increased its position in shares of Zeltiq Aesthetics by 1.2% in the third quarter. Municipal Employees Retirement System of Michigan now owns 9,910 shares of the company’s stock worth $389,000 after buying an additional 120 shares during the last quarter. PineBridge Investments L.P. increased its position in shares of Zeltiq Aesthetics by 4.9% in the second quarter. PineBridge Investments L.P. now owns 4,103 shares of the company’s stock worth $112,000 after buying an additional 193 shares during the last quarter. Finally, New York State Teachers Retirement System increased its position in shares of Zeltiq Aesthetics by 0.4% in the second quarter. New York State Teachers Retirement System now owns 47,852 shares of the company’s stock worth $1,308,000 after buying an additional 200 shares during the last quarter.

In related news, insider Mark J. Foley sold 10,000 shares of the business’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $37.26, for a total transaction of $372,600.00. Following the completion of the transaction, the insider now owns 311,274 shares in the company, valued at $11,598,069.24. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Keith J. Sullivan sold 8,000 shares of the business’s stock in a transaction on Friday, November 4th. The stock was sold at an average price of $33.01, for a total transaction of $264,080.00. Following the transaction, the insider now owns 82,023 shares of the company’s stock, valued at approximately $2,707,579.23. The disclosure for this sale can be found here. 15.60% of the stock is currently owned by company insiders.

Zeltiq Aesthetics Company Profile

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

5 Day Chart for NASDAQ:ZLTQ

Receive News & Stock Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related stocks with our FREE daily email newsletter.